Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery
Gels · 12.03.2024 · 10 (3) · 193
DOI: 10.3390/gels10030193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 12.03.2024. Verfasst von Fabrizio Villapiano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Naples Federico II, D. Montesano St. 49, 80131 Naples, Italy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Community—Next generation EU.
Abstract (Originalsprache)
This study endeavored to overcome the physiological barriers hindering optimal bioavailability in ophthalmic therapeutics by devising drug delivery platforms that allow therapeutically effective drug concentrations in ocular tissues for prolonged times. Thermosensitive drug delivery platforms were formulated by blending poloxamers (F68 and F127) with low-molecular-weight hyaluronic acid (HA) in various concentrations and loaded with hydrocortisone (HC). Among the formulations examined, only three were deemed suitable based on their desirable gelling properties at a temperature close to the eye’s surface conditions while also ensuring minimal gelation time for swift ocular application. Rheological analyses unveiled the ability of the formulations to develop gels at suitable temperatures, elucidating the gel-like characteristics around the physiological temperature essential for sustained drug release. The differential scanning calorimetry findings elucidated intricate hydrogel–water interactions, indicating that HA affects the water–polymer interactions within the gel by increasing the platform hydrophilicity. Also, in vitro drug release studies demonstrated significant hydrocortisone release within 8 h, governed by an anomalous transport mechanism, prompting further investigation for optimized release kinetics. The produced platforms offer promising prospects for efficacious ocular drug delivery, addressing pivotal challenges in ocular therapeutics and heralding future advancements in the domain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of Naples Federico II, D. Montesano St. 49, 80131 Naples, Italy.
- Medivis Srl, Carnazza St. 34/C, 95030 Tremestieri Etneo, Catania, Italy.
- Interdisciplinary Research Centre on Biomaterials (CRIB), Piazzale Tecchio 80, 80125 Naples, Italy.
- Department of Advanced Biomedical Sciences, University of Naples Federico II, S. Pansini St. 5, 80131 Naples, Italy.
ORCID-Profile: Teresa Silvestri, Virginia Campani, Sossio Fabio Graziano, Concetta Giancola, Federica D'Aria, Giuseppe De Rosa, Marco Biondi, Laura Mayol
Förderung
- European Community—Next generation EU
Zitieren
APA
Villapiano, F., Silvestri, T., Lo Gatto, C., Aleo, D., Campani, V., Graziano, S. F., Giancola, C., D'Aria, F., De Rosa, G., Biondi, M., & Mayol, L. (2024). Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery. Gels, 10(3), 193. https://doi.org/10.3390/gels10030193
Vancouver
Villapiano F, Silvestri T, Lo Gatto C, Aleo D, Campani V, Graziano SF, et al. Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery. Gels. 2024;10(3):193. doi:10.3390/gels10030193
BibTeX
@article{Villapiano2024,
author = {Villapiano, Fabrizio and Silvestri, Teresa and Lo Gatto, Camilla and Aleo, Danilo and Campani, Virginia and Graziano, Sossio Fabio and Giancola, Concetta and D'Aria, Federica and De Rosa, Giuseppe and Biondi, Marco and Mayol, Laura},
title = {Thermosensitive In Situ Gelling Poloxamers/Hyaluronic Acid Gels for Hydrocortisone Ocular Delivery},
journal = {Gels},
year = {2024},
volume = {10},
number = {3},
pages = {193},
doi = {10.3390/gels10030193}
}
EUVIMED